ÂÜÀòÂÒÂ×

Kevin Hershberger is an experienced financial executive with a proven track record in the healthcare and biotechnology sectors. Currently serving as Chief Financial Officer - Consulting at Bright Uro since November 2024, Kevin previously held multiple leadership roles at Lumicell from 2018 to 2024, including Chief Executive Officer and President, focusing on innovative cancer surgical technologies. Earlier positions include Chief Financial Officer at InVivo Therapeutics and ReWalk Robotics, where financial strategies were implemented to support clinical advancements and product commercialization. Kevin also has extensive experience at NxStage Medical, Boston Scientific, and USG, contributing to financial and operational leadership across various roles. Kevin holds a Bachelor of Science degree in Accounting from West Virginia University.